K2 Medical Research has entered a research pilot with Magruder Eye Institute and RetiSpec to use AI-driven technology to prescreen eligible candidates for clinical trials in an eye care setting. The collaboration aims to reduce the time needed to recruit eligible participants by using RetiSpec’s AI technology to detect neurological diseases through an eye exam. The technology may offer insights into early detection and intervention strategies for Alzheimer’s research. The partnership signifies a commitment to advancing medical research and improving clinical trial accessibility. The collaboration is seen as a significant milestone in the field of medical research and clinical trials.
Source link
Research collaboration aims to expand recruitment, improve access to clinical trials
